Abstract
"NO147: A Randomized Phase III Trial of Oxaliplatin Plus 5-Fluorouracil, and Leucovorin (Modified FOLFOX6) with or without Cetuximab after Curative Resection for Patients with Stage III Colon Cancer." Oncology Issues, 23(2), pp. 20–21 Additional informationNotes on contributorsSteven R. AlbertsSteven R. Alberts, MD, is the co-chair for the GI Committee with the North Central Cancer Treatment Group (NCCTG), Mayo Clinic College of Medicine, and the Mayo Clinic, Division of Medical Oncology in Rochester, Minn. Frank Sinicrope, MD, is the Translational Research Chair for the GI Committee with the North Central Cancer Treatment Group, Mayo Clinic College of Medicine.Frank SinicropeSteven R. Alberts, MD, is the co-chair for the GI Committee with the North Central Cancer Treatment Group (NCCTG), Mayo Clinic College of Medicine, and the Mayo Clinic, Division of Medical Oncology in Rochester, Minn. Frank Sinicrope, MD, is the Translational Research Chair for the GI Committee with the North Central Cancer Treatment Group, Mayo Clinic College of Medicine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
